| Conferences \ European Lab Automation \ Screening Europe - HTS & Compound Management \ Agenda \ Samu Melkko |
| Register | Login |
Automated State-of-the-Art Compound Profiling for Protease Drug TargetsThursday, 30 June 2011 at 14:15  Add to Calendar ▼2011-06-30 14:15:002011-06-30 15:15:00Europe/LondonAutomated State-of-the-Art Compound Profiling for Protease Drug TargetsSELECTBIOenquiries@selectbiosciences.comProteases are an important class of targets for drug discovery, with several protease inhibitors in the clinic for various indications. Similar to the well-established processes used in high-throughput screening (HTS), an automated compound profiling process for proteases has been introduced enabling high quality data and short turnaround times. Optimized workflows and a modular set-up of the processes provide the flexibility needed to support the unique needs of target-class oriented drug discovery programs with tailored solutions. |
Add to Calendar ▼2011-06-30 00:00:002011-07-01 00:00:00Europe/LondonScreening Europe - HTS and Compound ManagementSELECTBIOenquiries@selectbiosciences.com
